Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dartmet VG 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Addii Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Dartmet VG 1mg/500mg/0.2mg Tablet

Diabetol Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus, facilitating blood glucose regulation. Diabetol Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with well-controlled blood sugar. Discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Prompt recognition and treatment are essential. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Dartmet VG 1mg/500mg/0.2mg Tablet

No text provided to rephrase.

Uses of Dartmet VG 1mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Dartmet VG 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dartmet VG 1mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Dartmet VG 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Dartmet VG 1mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dartmet VG 1mg/500mg/0.2mg tablets on an empty stomach.

How Dartmet VG 1mg/500mg/0.2mg Tablet works:

Each Dartmet VG tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dartmet VG 1mg/500mg/0.2mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dartmet VG 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dartmet VG 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Dartmet VG 1mg/500mg/0.2mg Tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Dartmet VG 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dosage; the tablet is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Dartmet VG 1mg/500mg/0.2mg Tablet :

Should you forget a Dartmet VG 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dartmet VG 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dartmet VG 1mg/500mg/0.2mg Tablet

Dartmet VG 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Dartmet VG 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Patients with known allergies to Dartmet VG 1mg/500mg/0.2mg Tablet components or excipients, moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis) should not use this medication.
Combining Dartmet VG 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dartmet VG 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Dartmet VG 1mg/500mg/0.2m...
121
MRP 140
13% off